EmergingGrowth.com Reports on the January Effect and the biggest looser to benefit from it.
Ideas get bigger when you share them...
Miami, FL - December 18, 2012 (www.investorideas.com newswire) EmergingGrowth.com, a leading digital financial media company, Reports on The January Effect the biggest losers to benefit from it including Long Pine Resources (NYSE: LPR), GEVO Inc. (NASDAQ: GEVO), Supervalu, Inc. (NYSE: SVU) and others.
Feature your company on EmergingGrowth.com. Click here to find out how .
With the New Year only weeks away, investors are eagerly awaiting a yearly anticipated phenomenon known as the January Effect. The January Effect is simply a run on stocks, often following a poor December. Investors rush to buy securities prior the end of the year for a lower price, betting that the price will go up in January, and then dumping the stocks for a profit. A January Effect is often led by small-caps. According to Barron's, since 1926, small-cap stocks have beaten large caps 76% of the time in January. The best explanation offered for the January Effect is tax-related; that is, investors with portfolios that are weighted with small stocks sell off securities en bloc to claim venture losses and straight away reinvest after the New Year.
According to Jeffrey Hirsch of The Stock Trader's Almanac the January Effect is “Wall Street's only free lunch.” Free lunch or not, the January Effect can have multiple causes depending on the years market performance as a whole. Tax-loss selling that takes place in December is, more often than not, limited to individual investors. The average investor often concentrates his trading on low priced, higher-volatility small-cap stocks. As a result, it makes sense that some tax-loss selling in December focuses on small-cap names. Another cause is attributed to institutional investors. Many want to dump losing propositions from their portfolios before their end- of-year annual reports. And finally, some investors postpone of the sale of profitable stocks that achieved capital gains until January in order to defer taxes until following year.
So who were the biggest losers of 2012 and most likely to benefit from the January effect in 2013? Lone Pine Resources Inc. (NASDAQ: LPR) at -85.31% performance for the year is at the top of the list. It is currently trading at $1.01 and has a market cap of $86 million. Gevo Inc. (NASDAQ:GEVO) with a market cap of $58.91 million had a dismal performance of -77.58% in 2012. Shares are trading at $1.50. SUPERVALU Inc. (NYSE: SVU) stands at -65.95% for the year and is trading at $2.70. Groupon (NASDAQ: GRPN), one of the most highly touted IPOs of last year, came in at number five on the list with a per year performance at -76.73%. They should have taken Google (NASDAQ: GOOG) up on it's off to buy at $6 billion prior to going public in November of last year.
A final thought on strategy. It looks like the time frame for the January Effect is shifting forward a few weeks. If you are unsure of how to get your ‘free lunch' from the January Effect, try this alternative: purchase an S&P 600 small-cap exchange traded fund during mid December and sell it at the end of January. Such a strategy has yielded a 0.2% return over the past 10 years, compared with -0.9% loss in the S&P 1500. It has been successful in seven of those 10 years. Also you might be able to enhance performance by purchasing small-caps in mid-November, avoiding the worst of the underperformers, and in turn, selling in mid-January, to dodge the rush of sellers. Good luck!
By offering 100% original and unmatched content by the best financial reporters, writers and bloggers in the business, EmergingGrowth.com is emerging a leading digital financial media portal. Its services provide users, subscribers and advertisers with a variety of content and tools through a range of online, social media, mobile and other mobile outlets.
Since its inception, EmergingGrowth.com has distinguished itself from other financial media companies with its sly approach to reading between the lines in order to locate that needle in the haystack. Subscribe today to see what EmergingGrowth.com has to offer.
NEW: Feature your company on EmergingGrowth.com. Find out how by filling out our form at http://emerginggrowth.com/recommend-a-company-to-feature-on-emerging-growth
Join our Linked in Group
Like us on Facebook
This news is published on the Investorideas.com Newswire and its syndicated partner network
Get free news alerts:
Sign up here
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and global syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions and advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.